Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16076517rdf:typepubmed:Citationlld:pubmed
pubmed-article:16076517lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:16076517lifeskim:mentionsumls-concept:C0036341lld:lifeskim
pubmed-article:16076517lifeskim:mentionsumls-concept:C0066357lld:lifeskim
pubmed-article:16076517lifeskim:mentionsumls-concept:C0598608lld:lifeskim
pubmed-article:16076517lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:16076517lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:16076517pubmed:issue7lld:pubmed
pubmed-article:16076517pubmed:dateCreated2005-10-3lld:pubmed
pubmed-article:16076517pubmed:abstractTextIt has been suggested that total plasma homocysteine (tHcy) concentrations and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms are risk factors for schizophrenia. We conducted a case-control study to investigate whether tHcy levels and MTHFR C677T and A1298C variants are associated with schizophrenia, giving special consideration to confounding factors. Logistic regression analysis showed that neither tHcy nor MTHFR polymorphisms were associated with schizophrenia. Homozygosity for MTHFR C677T was associated with higher tHcy concentrations in control and schizophrenia groups (P<0.01), which was mainly driven by the male group. The A1298C variant did not show any association with tHcy concentrations. In conclusion, these results do not confirm an independent relationship of tHcy and MTHFR genotype with risk of schizophrenia.lld:pubmed
pubmed-article:16076517pubmed:languageenglld:pubmed
pubmed-article:16076517pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16076517pubmed:citationSubsetIMlld:pubmed
pubmed-article:16076517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16076517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16076517pubmed:statusMEDLINElld:pubmed
pubmed-article:16076517pubmed:monthSeplld:pubmed
pubmed-article:16076517pubmed:issn0278-5846lld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:ConA RARlld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:Fernández-Bal...lld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:VilellaElisab...lld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:LabadAntonioAlld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:MartorellLour...lld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:ValeroJoaquín...lld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:MurphyMichell...lld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:VirgosCarmenClld:pubmed
pubmed-article:16076517pubmed:authorpubmed-author:SimóJosep...lld:pubmed
pubmed-article:16076517pubmed:issnTypePrintlld:pubmed
pubmed-article:16076517pubmed:volume29lld:pubmed
pubmed-article:16076517pubmed:ownerNLMlld:pubmed
pubmed-article:16076517pubmed:authorsCompleteYlld:pubmed
pubmed-article:16076517pubmed:pagination1169-74lld:pubmed
pubmed-article:16076517pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:meshHeadingpubmed-meshheading:16076517...lld:pubmed
pubmed-article:16076517pubmed:year2005lld:pubmed
pubmed-article:16076517pubmed:articleTitleFurther evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.lld:pubmed
pubmed-article:16076517pubmed:affiliationPsychiatric University Hospital Institut Pere Mata, Unitat de Psiquiatria, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, C/Sant Llorenç 21, 43201 Reus, Spain. elisabet.vilella@urv.netlld:pubmed
pubmed-article:16076517pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16076517pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16076517pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4524entrezgene:pubmedpubmed-article:16076517lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16076517lld:entrezgene